Vertex Pharmaceuticals Inc VRTX:NASDAQ

Last Price$209.80NASDAQ Previous Close - Last Trade as of 4:00PM ET 11/15/19

Today's Change0(0.00%)
Bid (Size)$208.00 (2)
Ask (Size)$213.50 (1)
Day Low / HighN/A - N/A
Volume1.6 M
  • Latest Stories
  • Commentary and Analysis
Vertex Pharmaceuticals Says Wales Offer Accepted for Access to All Licensed Cystic Fibrosis Medicines
9:57AM ET 11/13/2019 MT Newswires

Vertex Pharmaceuticals (VRTX) has confirmed that the National Health Service in Wales, UK, has accepted an offer for all currently licensed Vertex cystic...

Analyst Actions: SunTrust Initiates Vertex Pharmaceuticals at Buy With $235 Price Target
7:42AM ET 11/12/2019 MT Newswires

Vertex Pharmaceuticals (VRTX) has an average rating among analysts of buy, with an average price target of $218. Price: 201.90, Change: +0.59, Percent...

Q4 and Full Year Earnings Estimates for Vertex Pharmaceuticals Forecasted Higher
5:16AM ET 11/08/2019 MT Newswires

Q4 and 2019 forecasted earnings estimate for Vertex Pharmaceuticals Inc (NASDAQ:VRTX, Recent Price: 195.83) for the quarter ending December 31, 2019 and...

2019 and Q3 Estimates for Vertex Pharmaceuticals Scaled Up but 2020 Earnings Number Decreased
7:56PM ET 11/04/2019 MT Newswires

Consensus forecasts for Q3 ending September 30, 2019, and the full year estimates for 2019 and 2020 for the years ending on December 31 for Vertex...

Q4, 2019, and 2020 Earnings Estimates for Vertex Pharmaceuticals Raised
10:41AM ET 11/01/2019 MT Newswires

Vertex Pharmaceuticals Inc's (NASDAQ:VRTX, Recent Price: 199.28) earnings forecasts for Q4 ending December 31, 2019, and the forecasts for 2019 and 2020...

Analyst Actions: Morgan Stanley Lifts Price Target on Vertex Pharmaceuticals to $250 From $240, Maintains Overweight
11:43AM ET 10/31/2019 MT Newswires

Vertex Pharmaceuticals (VRTX) has an average rating among analysts of buy, with an average price target of $216. Price: 199.05, Change: -0.23, Percent...

Analyst Actions: Piper Jaffray Lifts Price Target on Vertex Pharmaceuticals to $247 From $230, Maintains Overweight
11:42AM ET 10/31/2019 MT Newswires

Vertex Pharmaceuticals (VRTX) has an average rating among analysts of buy, with an average price target of $216. Price: 199.05, Change: -0.23, Percent...

Analyst Actions: Stifel Lifts Price Target on Vertex Pharmaceuticals to $229 From $211, Maintains Buy
11:42AM ET 10/31/2019 MT Newswires

Vertex Pharmaceuticals (VRTX) has an average rating among analysts of buy, with an average price target of $216. Price: 199.05, Change: -0.23, Percent...

Research Alert: CFRA Keeps Buy Opinion On Shares Of Vertex Pharmaceuticals Inc.
9:30AM ET 10/31/2019 MT Newswires

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as...

--Analyst Actions: RBC Raises Vertex Pharmaceuticals' Price Target to $235 From $210, Keeps Outperform Rating
8:49AM ET 10/31/2019 MT Newswires

Price: 198.45, Change: -0.83, Percent Change: -0.42 ...